Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
| Report ID | 153459 |
| Drug Identification Number | 02141019 |
| Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
| Common or Proper name | Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 10mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM GLUCONATE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-02-01 |
| Actual start date | 2022-03-01 |
| Estimated end date | 2022-12-31 |
| Actual end date | 2022-11-30 |
| Shortage status | Resolved |
| Updated date | 2022-12-05 |
| Company comments | Effective May 2, 2022, contract customers will be allocated 150% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-02-04 | English | Compare |
| v3 | 2022-02-02 | English | Compare |
| v2 | 2022-01-24 | French | Compare |
| v1 | 2022-01-24 | English | Compare |